Skip to content
Open access

Pulmonary arterial systolic pressure evolution after transcatheter edge-to-edge mitral valve repair and its association with outcomes

Oct 2026 · European Heart Journal · Vol 47 · 0 citations

TL;DR

Early reduction in sPAP after TEER is independently associated with improved long-term outcomes, and routine post-procedural sPAP assessment provides incremental prognostic value and should be systematically integrated into post-TEER echocardiographic evaluation.

Abstract

Transcatheter edge-to-edge repair (TEER) is the treatment of choice for high-surgical-risk patients with severe mitral regurgitation (MR). While persistent pulmonary hypertension (PH) predicts adverse outcomes after mitral valve surgery, its prognostic impact after TEER remains incompletely defined. To evaluate early changes in systolic pulmonary arterial pressure (sPAP) following TEER and their association with long-term outcomes. This multicenter international retrospective cohort study included 378 patients who underwent TEER between December 2012 and January 2023 across four centers. sPAP was measured by transthoracic echocardiography before the procedure and on day 1 post-TEER. PH was defined as sPAP >50 mmHg pre-TEER and >40 mmHg post-TEER. Patients were stratified into four groups: No PH, New PH, Normalized PH, and Persistent PH. The primary endpoint was a composite of all-cause mortality, heart failure hospitalization, or mitral valve reintervention. Median age was 80 years (IQR 74–85), and 57% were women. One hundred and sixty nine patients (46%) had degenerative mitral regurgitation. Baseline PH was present in 149 patients (39%). After TEER, 139 (37%) had No PH, 90 (24%) New PH, 48 (13%) Normalized PH, and 101 (27%) Persistent PH. Elevated post-TEER sPAP (aHR 2.0, 95% CI 1.4–2.9, p<0.01), residual MR ≥ moderate (aHR 2.9, 95% CI 1.8–4.5, p<0.01), and EuroSCORE II (aHR 1.1, 95% CI 1.0–1.1, p<0.01) independently predicted adverse events. A spline curve of the hazard ratio for the primary endpoint as a function of post-TEER sPAP (Figure 1) demonstrated a marked increase in risk above 40 mmHg. Event rates differed significantly across groups (Figure 2): compared with Persistent PH, Normalized PH (HR 0.28, 95% CI 0.15–0.54, p<0.01) and No PH (HR 0.49, 95% CI 0.33–0.73, p<0.01) were associated with lower risk, whereas New PH showed similar outcomes (HR 0.98, 95% CI 0.67–1.46, p=0.95). Chronic lung disease (aOR 3.5, 95% CI 0.9–13.2, p=0.04) and baseline NYHA class III–IV (aOR 0.4, 95% CI 0.2–1.0, p=0.04) were associated with persistent PH. Degenerative MR independently predicted new-onset PH (aOR 4.6, 95% CI 1.7–12.8, p<0.01). Early reduction in sPAP after TEER is independently associated with improved long-term outcomes. Routine post-procedural sPAP assessment provides incremental prognostic value and should be systematically integrated into post-TEER echocardiographic evaluation.Spline curve of HR for combined eventSurvival according to evolution of sPAP

Read PDF

Similar papers

Oct 2026

Periprocedural Pulmonary Hypertension and Outcomes After Mitral Valve Transcatheter Edge-to-Edge Repair.

BACKGROUND Pulmonary hypertension (PH) is common in patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER), but the prognostic significance of periprocedural PH changes remains uncertain. OBJECTIVES This study sought to evaluate the association between periprocedural PH patterns and clinical outc...

J. Miyamoto, Yohei Ohno, S. Noda et al. · 1 citation
Open access Oct 2026

Pulmonary Artery Denervation for Persistent Pulmonary Hypertension After Transcatheter Mitral Edge‐to‐Edge Repair: A Pilot Study and First Application in the Post M‐TEER Setting

ABSTRACT Pulmonary hypertension (PH) is common in patients undergoing transcatheter mitral edge‐to‐edge repair (M‐TEER) and is an established determinant of adverse outcomes after intervention. Importantly, persistent PH after technically successful M‐TEER remains associated with ongoing symptoms, right ventricular dys...

Xiang Chen, Ze-Ying Zhang, X. Lan et al. · 0 citations
Open access Oct 2026

Pulmonary arterial compliance independently predicts mortality after transcatheter tricuspid valve edge-to-edge repair

In severe tricuspid regurgitation (TR), right ventricular (RV) dysfunction and pulmonary hypertension (PH) drive adverse outcomes after transcatheter tricuspid valve edge-to-edge repair (T-TEER). RV-pulmonary arterial (RV-PA) coupling is a key prognostic marker; however, pulmonary arterial compliance (PAC) reflec...

F. Kazemi-Asrar, H. Brandes, C. Wolff et al. · 0 citations
Open access Oct 2026

Advanced and novel echocardiographic right ventricular function parameters predict outcomes after percutaneous mitral valve repair

Mitral regurgitation (MR) is a prevalent valvular disease, and mitral transcatheter edge-to-edge repair (M-TEER) is recommended for patients with severe MR who are inoperable or at high surgical risk. While M-TEER has shown comparable outcomes to conventional surgery, over 10% of patients experience mortality, an...

R. Mistrulli, I. R. Ilaria Rubino, T. S. Tatyana Storozhenko et al. · 0 citations
Open access Oct 2026

Predictors of early death after transcatheter edge-to-edge mitral valve repair: results from the MAVERICK registry

Transcatheter edge-to-edge mitral valve repair (TEER) has become an established treatment for patients with severe mitral regurgitation (MR) at high surgical risk. Given its low procedural risk, TEER is frequently offered even to the highest-risk patients, raising concerns about the lack of meaningful clinical be...

A. Souquet, J. Mesnier, C. Nguyen et al. · 0 citations
Open access Oct 2026

Echocardiographic markers of residual pulmonary vascular disease and clinical risk after transcatheter mitral valve edge-to-edge repair

Pulmonary hypertension (PH) is common in patients with chronic mitral regurgitation (MR) and advanced left-sided heart failure (HF) undergoing transcatheter mitral valve edge-to-edge repair (mTEER). While mTEER effectively reduces left atrial (LA) pressure and MR severity, a substantial subset of patients exhibit...

F. Guzman, Y. Weiss, J. N. Dela Cruz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.